Harald Renz

Jan 1, 2024 | sciencedirect.com | Chrysanthi Skevaki |Harald Renz

Rethinking PIDs: Why the distinction between primary and secondary immune disorders is more frequently relevant than that between inborn and acquired errors of immunityDisclosure of potential conflict of interest: The author declares that he has no relevant conflicts of interest.

Aug 1, 2023 | nature.com | Pavel Kolkhir |Thomas Bieber |Emma Guttman-Yassky |Martin Metz |Harald Renz

AbstractOver the past two decades, significant progress in understanding of the pathogenesis of type 2 chronic inflammatory diseases has enabled the identification of compounds for more than 20 novel targets, which are approved or at various stages of development, finally facilitating a more targeted approach for the treatment of these disorders.